Skip to content

Evaluation of respiratory Tele-rehabilitation in patient with COVID-19

The impact of respiratory Tele-rehabilitation on pulmonary function and quality of life in patient with COVID-19

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200711048077N1
Enrollment
60
Registered
2020-11-16
Start date
2020-11-21
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus 2019. COVID-19, virus identified

Interventions

Intervention 1: Intervention group: For four weeks, every day for 30 minutes once a day for two set with 10 minutes of rest and hydration. The program includes one-minute diaphragmatic breathing exerc

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Willingness to participate in the study Acceptable visual, auditory and alertness to participate in study Ability to understand and speak Persian Having online communication facilities such as internet and one of the smart devices such as laptop, tablet or smartphone. Ability to use online technology or caregiver to access it during quarantine. Patients who have been diagnosed with covid 19 and have a lung lesion based on the results of a CXR or CT scan with the approval of an infectious disease specialist Discharge after treatment Observance of social isolation Having a cardiac echo at the time of admission that indicates heart health

Exclusion criteria

Exclusion criteria: Having deformity in the chest mental disorder Any severe illness that impairs the movement of patients such as severe heart disease, severe musculoskeletal pain, vascular aneurysms, severe neurological diseases Pregnancy vestibular disorders

Design outcomes

Primary

MeasureTime frame
Pulmonary function. Timepoint: At the beginning of the study (before the intervention) and at the end of the second week and at the end of the fourth week after the intervention. Method of measurement: By examining the six-minute walk test and measuring the maximum inspiratory pressure (MIP) and the percentage of blood oxygen saturation (SPO2).;Quality of life score in SF-36 questionnaire. Timepoint: At the beginning of the study (before the intervention) and at the end of the second week and at the end of the fourth week after the intervention. Method of measurement: SF-36 questionnaire.

Secondary

MeasureTime frame
Six-minute walking test (6mwt). Timepoint: At the beginning of the study (before the intervention) and at the end of the second week and at the end of the fourth week after the intervention. Method of measurement: The patient walks a 30-meter flat path in six minutes and the distance is measured.;Maximum inspiratory pressure (MIP). Timepoint: At the beginning of the study (before the intervention) and at the end of the second week and at the end of the fourth week after the intervention. Method of measurement: En IMT K1 POWER BREATH device.;Peripheral capillary oxygen saturation. Timepoint: At the beginning of the study (before the intervention) and at the end of the second week and at the end of the fourth week after the intervention. Method of measurement: Pulse Oximeter.;Fatigue and dyspnea score. Timepoint: At the beginning of the study (before the intervention) and at the end of the second week and at the end of the fourth week after the intervention. Method of measurement: Borg scale 6-20.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme Rangani

Mashhad University of Medical Sciences

ranganif981@mums.ac.ir+98 51 3864 6372

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026